Skip to main content

Table 1 HCV prevalence data by country

From: Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries

Country (2016 total population) National anti-HCV prevalence estimate (%) Adult anti-HCV prevalence Gower, et al. (%) Estimated number of anti-HCV+ people Estimated anti-HCV prevalence among PWID (%) Estimated anti-HCV prevalence among PLHIV (%) Key populations specified
Armenia (2994400) 4   120,000 52.1 17.9 Migrants, PWID
Azerbaijan (9705600) 3.2 3.1 300,800 62.8 5.9 PWID
Belarus (9498700) 2–3 1.3 250,000 70–95   PWID
Georgia (3720400) 7.5   208,800 57–74 4.8 PWID, MSM, healthcare workers
Kazakhstan (17753200) 1.5–3 3.3 255,000–510,000 % not available (estimated 6049 people) 4.5  
Kyrgyzstan (6019500) 4 2.5 220,000 45.2 80  
Moldova (3553100) 1.7–4 4.5 60,000–142,000 35.3–65.4 4.6 PWID
Russia (146544710) 4 4.1 5,900,000 69 27 PWID
Tajikistan (8547000) 2.3 3.1 200,000 22.7–49.3 25.6% among HIV+ PWID PWID
Ukraine (42708647) 5   2,135,000 55   PWID; hemophiliacs, hemodialysis patients; MSM; PMTCT clients
Uzbekistan (31575300) 6.5   1,800,000 36   Healthcare workers, PWID, patients receiving invasive treatment